These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21666497)

  • 1. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model.
    Lahiani-Cohen I; Lourbopoulos A; Haber E; Rozenstein-Tsalkovich L; Abramsky O; Grigoriadis N; Rosenmann H
    J Neuropathol Exp Neurol; 2011 Jul; 70(7):610-21. PubMed ID: 21666497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy.
    Boimel M; Grigoriadis N; Lourbopoulos A; Touloumi O; Rosenmann D; Abramsky O; Rosenmann H
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):314-25. PubMed ID: 19225406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
    Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
    Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
    Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
    J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model.
    Yoshiyama Y; Uryu K; Higuchi M; Longhi L; Hoover R; Fujimoto S; McIntosh T; Lee VM; Trojanowski JQ
    J Neurotrauma; 2005 Oct; 22(10):1134-41. PubMed ID: 16238489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
    Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
    Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tau pathology in tau transgenic models.
    Brion JP; Ando K; Heraud C; Leroy K
    Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice.
    Boimel M; Grigoriadis N; Lourbopoulos A; Haber E; Abramsky O; Rosenmann H
    Exp Neurol; 2010 Aug; 224(2):472-85. PubMed ID: 20546729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.
    Klein RL; Lin WL; Dickson DW; Lewis J; Hutton M; Duff K; Meyer EM; King MA
    Am J Pathol; 2004 Jan; 164(1):347-53. PubMed ID: 14695347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice.
    Morcinek K; Köhler C; Götz J; Schröder H
    Brain Res; 2013 Feb; 1497():73-84. PubMed ID: 23261664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
    Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.